Table 3. Aranesp dose and haemoglobin response in spite of persistence of EPO antibodies and without the need of blood transfusions
| Date | 08/11/01 | 03/01/02 | 18/02/02 | 19/06/02 | 22/07/02 | 23/08/02 | 16/10/02 |
|---|---|---|---|---|---|---|---|
| Aranesp mcg/wk | 40 | 40 | 40 | 40 | 20 | 20 | 30 |
| Hb g/dl | 9.4 | 10.7 | 9.7 | 14.3 | 15.2 | 14.4 | 13.1 |
| EPO antibodies | — | — | positive | positive | positive | — | — |
| Transfusion | Yes | No | No | No | No | No | No |